Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

GlaxoSmithKline Pharmaceuticals Price Movement Clarification

GlaxoSmithKline Pharmaceuticals clarified that recent trading volume increases are purely market-driven. The company confirmed all material disclosures have been made according to SEBI regulations.

Source

BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

GlaxoSmithKline Pharmaceuticals Ltd: key numbers

Share price
₹2,498.00
Market cap
₹42,318 Cr
Revenue (annual)
₹3,822 Cr
Net profit (annual)
₹1,036 Cr
P/E (TTM)
39.6×Sector 46.1×
Promoter holding
75.00%+0.00% QoQ
FII holding
4.75%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from GlaxoSmithKline Pharmaceuticals Ltd

All →

Other price movement clarification announcements

All →